Astrana Health, Inc. (ASTH)
NASDAQ: ASTH · Real-Time Price · USD
36.20
+0.64 (1.80%)
Aug 3, 2026, 1:43 PM EDT - Market open
Astrana Health Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 3,526 | 3,182 | 2,035 | 1,387 | 1,144 | 773.92 | |
Revenue Growth | 56.69% | 56.39% | 46.72% | 21.19% | 47.84% | 12.62% |
Cost of Revenue | 3,151 | 2,840 | 1,763 | 1,172 | 944.69 | 596.14 |
Gross Profit | 375.95 | 341.53 | 271.39 | 214.96 | 199.48 | 177.77 |
Selling, General & Admin | 235.1 | 217.26 | 154.11 | 112.6 | 77.67 | 62.08 |
Depreciation & Amortization Expenses | 54.38 | 45.75 | 27.93 | 17.75 | 17.54 | 17.52 |
Total Operating Expenses | 289.48 | 263.01 | 182.04 | 130.35 | 95.21 | 79.59 |
Operating Income | 86.47 | 78.53 | 89.35 | 84.61 | 104.27 | 98.18 |
Interest Income | 17.96 | 13.87 | 18.96 | 19.79 | 7.6 | -2.74 |
Interest Expense | -17.72 | -49.93 | -33.1 | -16.1 | -7.92 | -5.39 |
Other Non-Operating Income (Expense) | 4 | -2.86 | 5.61 | 1.54 | -17.33 | -12.3 |
Total Non-Operating Income (Expense) | -36.76 | -38.92 | -8.53 | 5.23 | -17.65 | -20.43 |
Pretax Income | 49.71 | 39.61 | 80.82 | 89.84 | 86.62 | 77.75 |
Provision for Income Taxes | 18.73 | 15.53 | 30.89 | 31.99 | 40.88 | 31.69 |
Net Income | 30.99 | 24.08 | 49.93 | 57.85 | 45.74 | 46.06 |
Minority Interest in Earnings | 0.76 | 1.59 | 6.78 | -2.87 | 0.57 | -22.87 |
Net Income to Common | 30.23 | 22.49 | 43.15 | 60.72 | 45.17 | 68.92 |
Net Income Growth | -13.64% | -47.88% | -28.93% | 34.42% | -34.46% | 82.88% |
Shares Outstanding (Basic) | 49 | 49 | 48 | 47 | 45 | 44 |
Shares Outstanding (Diluted) | 49 | 49 | 48 | 47 | 46 | 45 |
Shares Change | 2.41% | 2.91% | 2.20% | 2.94% | 0.44% | 21.24% |
EPS (Basic) | 0.62 | 0.46 | 0.91 | 1.30 | 1.00 | 1.57 |
EPS (Diluted) | 0.61 | 0.46 | 0.90 | 1.29 | 0.99 | 1.52 |
EPS Growth | -16.44% | -48.89% | -30.23% | 30.30% | -34.87% | 50.50% |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 154.99 | 104.49 | 44.17 | 39.7 | 59.19 | 51.11 |
Free Cash Flow Growth | 197.39% | 136.58% | 11.26% | -32.93% | 15.80% | 13.58% |
Free Cash Flow Per Share | 3.14 | 2.12 | 0.92 | 0.85 | 1.30 | 1.13 |
Gross Margin | 10.66% | 10.73% | 13.34% | 15.50% | 17.43% | 22.97% |
Operating Margin | 2.45% | 2.47% | 4.39% | 6.10% | 9.11% | 12.69% |
Profit Margin | 0.88% | 0.76% | 2.45% | 4.17% | 4.00% | 5.95% |
FCF Margin | 4.40% | 3.28% | 2.17% | 2.86% | 5.17% | 6.60% |
EBITDA | 140.85 | 124.27 | 117.28 | 102.36 | 121.81 | 115.7 |
EBITDA Margin | 3.99% | 3.91% | 5.76% | 7.38% | 10.65% | 14.95% |
EBIT | 86.47 | 78.53 | 89.35 | 84.61 | 104.27 | 98.18 |
EBIT Margin | 2.45% | 2.47% | 4.39% | 6.10% | 9.11% | 12.69% |
Effective Tax Rate | 37.67% | 39.21% | 38.22% | 35.61% | 47.19% | 40.76% |